BofA Securities analyst Bryan Spillane reiterated a Buy rating on the shares of Colgate-Palmolive Company (NYSE:CL) and raised the price target from $90 to $100. CL opened the year with organic sales ...
Colgate-Palmolive's premiumization strategy and pet nutrition expansion offer significant growth potential, with a price target of $115 per share, suggesting a 26% upside. Despite high valuation ...
Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral HealthMulti-year funding will advance oral health, ...
Press Trust of India on MSN
Colgate-Palmolive's integrated CSR and ESG initiatives create an impact on health, dignity and community well-being
MUMBAI, India, Jan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback